The role of the basolateral amygdala (BLA) in the consolidation of aversive memory is well established. Here we investigate the involvement of the histaminergic system in BLA on this variable. Rats were chronically implanted with bilateral cannulae in the BLA and after recovery were trained in a one-trial step-down inhibitory avoidance task. Immediately after training histaminergic compounds either alone or in combination were infused through the cannulae. Memory was assessed in test sessions carried out 24 h after the training session. Post-training histamine (1-10 nmol ; 0.5 ml/side) enhanced consolidation and the histamine H 3 receptor antagonist thioperamide (50 nmol ; 0.5 ml/side) impaired memory consolidation. The effect was shared by the histamine N-methyltransferase inhibitor SKF-91844 (50 nmol ; 0.5 ml/side) as well as by the H 3 receptor agonist imetit (10 nmol ; 0.5 ml/side). The promnesic action of histamine was unaffected by the H 1 receptor antagonist pyrilamine (50 nmol ; 0.5 ml/side). The H 1 receptor agonist pyridylethylamine (10 nmol ; 0.5 ml/side), the H 2 agonist dimaprit (10 nmol ; 0.5 ml/side) and the H 2 antagonist ranitidine (50 nmol ; 0.5 ml/side) were ineffective. Histaminergic compounds infused into the BLA had no effect on open-field or elevated plus-maze behaviour. The data show that histamine induces a dose-dependent mnemonic effect in rats and indicate that this reflects a role of endogenous histamine in the BLA mediated by H 3 receptors.
Introduction
Histamine given post-training in various brain regions modulates memory consolidation of various learning tasks. The first description of memory modulation by histamine was an enhancement of the consolidation of one-trial inhibitory avoidance (IA) with post-training i.c.v. administrations (Almeida and Izquierdo, 1986) . In that paper, histamine was effective at low doses (1 or 10 ng/rat) and was blocked by both promethazine and cimetidine but not by either drug alone. Since then, the effects on memory of histamine, histamine releasers, enhancers and antagonists given in various structures of the brain were studied in different forms of memory. Some reports have concluded that histamine facilitates consolidation and others that it depresses it by action on different receptors in different brain sites (Cacabelos and Alvarez, 1991 ; Frisch et al., 1999 ; Spieler et al., 1999 ; Passani et al., 2001 ; Cangioli et al., 2002 ; Giovannini et al., 2003 ; Alvarez and Ruarte, 2004 ; Baldi et al., 2005 ; Da Silva et al., 2006 ; Liu et al., 2007 ; Alvarez and Banzan, 2008 ; Foley et al., 2009 ; Bonini et al., 2011 ; Charlier and Tirelli, 2011 ; Benetti et al., 2012a, b) so the overall picture is far from clear. It is possible that at some receptors and in some brain areas, histamine enhances memory consolidation of certain tasks, and at other receptors and in other areas or tasks it may have different effects. For example, memory facilitation of IA has been described both with histamine given i.c.v. (Almeida and Izquierdo, 1986) and with pharmacological inhibition of the tuberomammilary nucleus, the source of brain histamine (Frisch et al., 1999) . Many histamine effects on memory have been attributed to histamine H 1 , H 2 or H 1 plus H 2 receptors (Almeida and Izquierdo, 1986 ; Alvarez and Ruarte, 2004 ; Alvarez and Banzan, 2008 ; Benetti et al., 2012a ) but as will be seen later, clearly other effects in areas critical for memory formation are mediated by H 3 receptors (Benetti et al., 2012a) . Interestingly, the H 3 receptor antagonist thioperamide has been reported to enhance consolidation in some tasks or brain regions (Ghi et al., 1998 ; Molinengo et al., 1999 ; Orsetti et al., 2002 ; Bernaerts et al., 2004 ) and as will be seen later, also to antagonize the enhancing action of histamine in others.
The basolateral nuclear complex of the amygdala (BLA) has been repeatedly and convincingly shown to modulate the memory consolidation of one-trial IA in the rat and various other species (McGaugh, 2004 ; Izquierdo et al., 2006) and has been relatively little explored in connection with histamine effects on this process. Various types of histamine receptors in the BLA have been described and it has been suggested that they may play a role in the consolidation of different tasks (see Alvarez and Ruarte, 2004 ; Fiorenza et al., 2012) . Here we study the effect of histamine, of an enhancer of histamine action, N-methyltransferase inhibitor SKF-91488 and of different histamine receptor blockers micro-infused immediately post-training into the BLA on memory consolidation of one-trial IA in rat.
Materials and method

Subjects
Male Wistar rats (aged 2.5-3 months ; 290-330 g) purchased from the State Center for Production and Research in the Health Sciences, our regular provider, were housed five to a cage with water and food (Purina lab pellets) ad libitum, under a 12-h light/12-h dark cycle (lights on 07:00 hours). The temperature of the animal room was maintained at 22-24 xC. All procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Bioethics Committee of the University.
Surgery, handling and habituation to experimenter
At least 5 d after their arrival the animals were implanted with 75 mg/kg ketamine plus 10 mg/kg xylazine anaesthesia with bilateral 22-g guide cannulas aimed 1.0 mm above the BLA (A x2.8, L ¡4.7, V x7.5 mm). Coordinates are from the atlas by Paxinos and Watson (1998) . After 4-7 d recovery from surgery, the animals were handled by the experimenter gently touching and holding the rat with two hands using gloves, for approximately 5 min, once daily for two consecutive days. After this they were trained in the IA procedure between 08:00 and 11:00 hours.
Training was carried out in a 50r25r25 cm plexiglass box with 5 cm-high, 7 cm-wide and 25 cm-long Formica platform on the left end of a series of 0.3 cm-calibre bronze bars spaced 1.0 cm apart that made up the floor of the box. The animals were placed on the platform facing the rear left corner of the training box. When they stepped down placing their four paws on the grid they received a 2 s 0.5 mA scrambled foot shock and were then withdrawn from the apparatus. Later (24 h) they were again placed on the platform as described and allowed to move freely without receiving a foot shock when they stepped down.
Step-down latency was measured in the training and the test session with a chronometer activated automatically. Drug or vehicle treatments were administered immediately after the training session.
Step-down latencies were cut-off at 300 s in the test session (Da Silva et al., 2006 ; Bonini et al., 2011 ; Benetti et al., 2012b ; Fiorenza et al., 2012) .
Drug infusions
Rats were infused intra-BLA bilaterally, first on the right side and 30 s later on the left side, through a 5 ml Hamilton syringe coupled to a pump (EICOM, Japan) at a flow rate of 0.5 ml/min ; infusion cannulas were left in place 30 s after each infusion so as to minimize backflow. The doses used were chosen from those described in the literature as being effective, based on pilot experiments.
Open field and plus maze
To analyse their locomotor and exploratory activities, animals were placed in a 50r50r39 cm open-field arena with the floor divided into 12 equal rectangles. Line crossings and rearings were measured over a 5 min period. To evaluate their anxiety state, rats were exposed to an elevated plus maze as described by Pellow et al. (1985) and more recently by Benetti et al. (2009) . The total number of entries into the four arms and the number of entries and time spent into the open arms were recorded over a 5-min session. The animals used for IA training were not reutilized in open-field and plus-maze experiments. Twenty-four hours before exposure to the open field or the plus maze, the animals received 0.5 ml/side bilateral infusions of the treatments as shown in Table 1 , in the BLA. All behavioural observations were carried out in the light part of the light/dark cycle (lights on 07.00 hours).
Statistics
Data obtained in IA were expressed as medians and interquartile range and were analysed by a non-parametric analysis of variance (ANOVA) test, the Kruskal-Wallis test, followed by Dunn's multiple comparison tests. We used non-parametric statistics for this measure because the ceiling of 300 s caused the results to be non-Gaussian. Data obtained on the plus maze and open-field test were expressed as by means¡S.E.M. and were analysed by oneway ANOVA for repeated measures followed by post hoc Newman-Keuls tests comparing all pairs of columns. Probability p<0.05 was considered significant.
Correct cannula placements are shown in Fig. 1 . They were established by measuring the spread of infusions of 0.5 ml 4 % Methylene Blue over 30 s into BLA at the coordinates mentioned earlier, 2 d after the final behavioural procedure. The spread of the dye was taken as an estimate of that of the drug infusions in the same animals. Placements were considered correct when the spread was fl mm 3 from the intended infusion sites ; this occurred in 98 % of the animals. Although we do not know the diffusion rate of the dye or that of the drugs used, clearly this procedure is an improvement over the mere verification of the cannula tip position.
Results
As shown in Fig. 2 , histamine at the dose of 1 or 10 nmol/side enhanced memory consolidation in comparison with saline : p<0.0001 in a one-way KruskalWallis test followed by a Dunn's multiple comparison test. The difference between the effect of both doses was also significant (p<0.001).
The enhancing effect of the histamine potentiator, SKF-91488 was significant at the level of p<0.01 in a Kruskal-Wallis test followed by a Dunn's multiple comparison tests and was therefore similar to that of histamine. However, its effect was fully antagonized by the co-infusion SKF-91488 plus thioperamide ; p<0.0001 in a Kruskal-Wallis test followed by a Dunn's multiple comparison test (Fig. 3) .
The antagonists of each histaminergic receptor H 1 , H 2 or H 3 in comparison with saline had no effect on their own (Fig. 4) at the doses given (p>0.05 ; one-way ANOVA, non parametric Kruskal-Wallis test followed by Dunn's multiple comparison test). However, interestingly the H 3 antagonist thioperamide co-infused with histamine blocked the enhancing effect of 10 nmol histamine (p<0.0001 in comparison with the other two antagonists pyrilamine and ranitidine co-infused with histamine). Furthermore, histamine at a dose of 10 nmol and histamine plus pyrilamine replicated the enhancement in aversive memory consolidation in comparison with saline (p<0.01 in a Kruskal-Wallis test followed by Dunn's multiple comparison tests ; Fig. 5 ). Fig. 2 . Infusion of histamine into the basolateral nuclear complex of the amygdala (BLA) enhances aversive memory in rats and in a specific drug concentration. Histamine dose-response curve in three different concentrations (0.1, 1.0 or 10 nmol) per side were bilaterally infused (0.5 ml) into the BLA immediately after inhibitory avoidance training. TR, Training session step-down latency. Bars represent median (¡interquartile range) stepdown latencies during a memory retention test carried out 24 h after training. n=number of animals per group. *** p<0.0001 (one-way analysis of variance) non-parametric Kruskal-Wallis test followed by Dunn's multiple comparison test.
The H 3 agonist, imetit (p<0.0001) unlike the other two histamine receptor agonists tested, enhanced consolidation on its own in a Kruskal-Wallis test followed by Dunn's multiple comparison test (Fig. 6) .
None of the treatments tested had any effect on openfield or plus-maze performance (Table 1) , which rules out an influence on hippocampus/BLA independent of memory.
Discussion
Clearly, histamine enhances memory consolidation in the BLA and the effect is attributable to an action upon H 3 receptors, inasmuch as it is mimicked by the H 3 agonist imetit and blocked by the H 3 antagonist, thioperamide. It appears to reflect an influence of endogenous histamine as suggested by the action of the inhibitor of histamine catabolism, SKF-91488 and its reversal by thioperamide. The effect would appear to occur independently of the H 2 receptor-mediated histamine facilitation of consolidation processes for this task in the hippocampus (Da Silva et al., 2006) . All types of histamine receptor have been found in the BLA and have been attributed different functions on the basis of pharmacological experiments (Passani et al., 2001 ; Cangioli et al., 2002 ; Jiang et al., 2005 ; Bananej et al., 2012) .
The present findings add to the growing evidence for a role of histamine in memory modulation (see references in Introduction). Unlike its role in consolidation of IA in the hippocampus, which as stated is mediated by H 2 Step-down latency (s) TR *** * Saline (n=13) SKF 91488 (n=10) SKF 91488 + Thioperamide (n=10) Fig. 3 . N-methyltransferase inhibitor SKF-91488 mimics the enhancement of consolidation caused by histamine and its effect is antagonized by thioperamide. SKF-91844 (50 nmol), or a solution with thioperamide (50 nmol) plus SKF-91488 (50 nmol) were prepared and were bilaterally infused (0.5 ml) into the basolateral nuclear complex of the amygdala immediately after inhibitory avoidance training. TR, Training session step-down latency. Bars represent median (¡interquartile range) step-down latencies during a memory retention test carried out 24 h after training ; n=number of animals per group. * p<0.01 and *** p<0.001 (one-way analysis of variance) non-parametric Kruskal-Wallis test followed by Dunn's multiple comparison test. Step-down latency (s) TR Ranitidine (n=10) Thioperamide (n=10) Pirilamine (n=13) Saline (n=13) Fig. 4 . Effects of antagonists of H 1 , H 2 , H 3 histamine receptors infused into the basolateral nuclear complex of the amygdala immediately after training in inhibitory avoidance task in rats. H 1 antagonist pyrilamine, the H 2 antagonist ranitidine and the H 3 antagonist thioperamide were bilaterally infused (0.5 ml) into the basolateral nuclear complex of the amygdala after inhibitory avoidance training at 50 nmol/side. Any one histaminergic antagonist receptor showed specific effects in blockage aversive memory. TR, training session step-down latency. Bars represent median (¡interquartile range) step-down latencies during a memory retention test carried out 24 h after training ; n=number of animals per group. p<0.05 (one-way analysis of variance) non-parametric Kruskal-Wallis test followed by Dunn's multiple comparison test. Step-down latency (s) 50 0 ** ** *** Fig. 5 . Aversive memory enhancement induced by the intra basolateral nuclear complex of the amygdala (BLA) infusion of histamine and SKF-91488 was blocked by H 3 , but not H 1 and H 2 antagonists of histaminergic receptors. Rats received bilateral infusions intra-BLA (0.5 ml) of saline, histamine (10 nmol/side) or a prepared solution with histamine (10 nmol/side) plus another specific antagonists (50 nmol/side) receptors, or in the consolidation of extinction, which is also mediated by H 2 receptors but in BLA, hippocampus and ventromedial prefrontal cortex simultaneously (Fiorenza et al., 2012) , the facilitatory influence of histamine on IA consolidation in BLA is mediated by H 3 receptors sensitive to imetit and thioperamide. H 3 receptors also mediate the enhancing role of histamine in consolidation of conditioned fear in the nucleus basalis magnocellularis (Benetti et al., 2012a ). In other tasks, H 3 receptor blockade has been reported to actually improve memory consolidation (Passani et al., 2001 ; Orsetti et al., 2002) . H 3 receptor agonists increase (Cangioli et al., 2002) and H 3 antagonists decrease the spontaneous release of acetylcholine in the BLA (Passani et al., 2001) . Thus, it has been speculated that histamine actions on H 3 receptors may depend at least in part on influences on cholinergic transmission (see Benetti et al., 2012b) . Muscarinic cholinergic transmission in BLA is widely regarded as important for memory consolidation in various tasks (Power et al., 2003) . Curiously, thioperamide reverses amnesia induced by MK-801 or scopolamine (Bernaerts et al., 2004) . Furthermore, histamine H 2 receptor stimulation in the CA1 of dorsal hippocampus has recently been shown to counteract the deleterious effect on the consolidation of one-trial avoidance brought about by the cholinergic dysfunction created by early maternal deprivation in rats (Benetti et al., 2012b ). Although we have no way of knowing if the spread of the dye was identical to that of the infused substances, clearly this procedure gives a better estimate than that provided by the mere localization of the cannula tips.
In addition, the present findings on thioperamide are at odds with others reported in the literature with other H 3 receptor antagonists that have promnesic effects of systemic or intracerebral effects on memory consolidation (Fox et al., 2005 ; Medhurst et al., 2007 ; Esbenshade et al., 2008 ; Giannoni et al., 2010 ; Passani and Blandina, 2011) . This may be due to a number of factors, among which a different amount of acetylcholine modulatory release by H 3 auto-receptors or hetero-receptors in different tasks or situations and different access of the drug(s) to the BLA or other sites of action in the H 3 receptors are known to influence the release of acetylcholine in BLA (Cangioli et al., 2002) . Other transmitters with dopamine, noradrenaline and acetylcholine in other brain areas within cingulated cortex (Medhurst et al., 2007 ; Esbenshade et al., 2008 ; Giannoni et al., 2010) including histamine itself may mediate their influence on behaviour totally or partially (Cangioli et al., 2002 ; Kö hler et al., 2011 ; Benetti et al., 2012b) .
The outcome of histaminergic effects on memory processes in the BLA or, for that matter, elsewhere, certainly depends on the relative participation of the various histamine receptor types in the function of the brain area being investigated and in the case of H 3 receptors, of the relative involvement of other neurotransmitters released by stimulation of those receptors. In addition, it is very likely that for different tasks the modulatory influences of histaminergic and other synapses (catecholaminergic, etc.) operate differentially, as recently shown for contextual fear conditioning and IA (see Fiorenza et al., 2012) .
Finally, the results showed here, together with others that have been published previously are coherent with the hypothesis that the histaminergic system could provide a crucial mechanism to fine tune amygdala for an adequate behavioural response. Therefore, clearly, the H 3 receptor-mediated role of histamine in the BLA in memory consolidation of one-trial avoidance described here is something different from, and parallel to, other histaminergic actions on the modulation of memory. Step-down latency (s) 50 0 Fig. 6 . Consolidation of aversive memory can be enhanced in rats by the infusion of specific histaminergic H 3 agonist imetit into the basolateral nuclear complex of the amygdala. Rats trained in inhibitory avoidance task received bilateral infusion (0.5 ml) of saline, agonist H 1 pyridylethylamine (10 nmol/side), agonist H 2 dimaprit (10 nmol/side) or H 3 agonist imetit (10 nmol/side). H 1 and H 2 agonists had no effect but imetit caused aversive memory enhancement. TR, Training session step-down latency. Bars represent median (¡interquartile range) of step-down latencies during a memory retention test carried out 24 h after training, n=number of animals per group ; *** p<0.001 (one-way analysis of variance) non-parametric Kruskal-Wallis test followed by Dunn's multiple comparison test.
